1. Home
  2. FLOC vs VOR Comparison

FLOC vs VOR Comparison

Compare FLOC & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowco Holdings Inc.

FLOC

Flowco Holdings Inc.

HOLD

Current Price

$19.31

Market Cap

949.8M

Sector

Industrials

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$20.10

Market Cap

813.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLOC
VOR
Founded
1996
2015
Country
United States
United States
Employees
1281
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
949.8M
813.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FLOC
VOR
Price
$19.31
$20.10
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$28.50
$45.33
AVG Volume (30 Days)
831.2K
1.6M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
1.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.92
N/A
Revenue Next Year
$8.59
N/A
P/E Ratio
$16.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.03
$1.62
52 Week High
$28.26
$49.95

Technical Indicators

Market Signals
Indicator
FLOC
VOR
Relative Strength Index (RSI) 29.21 73.35
Support Level $17.46 $11.62
Resistance Level $24.37 $49.95
Average True Range (ATR) 1.03 1.39
MACD -0.26 0.64
Stochastic Oscillator 13.41 76.44

Price Performance

Historical Comparison
FLOC
VOR

About FLOC Flowco Holdings Inc.

Flowco Holdings Inc is a provider of production optimization, artificial lift, emissions management, and monetization solutions for the oil and natural gas industry. Its technologies include high-pressure gas lift (HPGL), conventional gas lift, plunger lift, and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions, which includes rental services, and Natural Gas Technologies, which include service, gas compression parts, and equipment sales. Production Solutions: relates to rentals, sales, and services related to high-pressure gas lift, conventional gas lift, and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue. It generates maximum revenue from the United States.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: